This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WASHINGTON — A new memo from the White House budget office indicates that Medicaid payments should not be affected by a pause on some federal grants. States, though, on Tuesday were reporting difficulties accessing Medicaid payment portals. “Mandatory programs like Medicaid and SNAP will continue without pause,” the White House Office of Management and Budget stated in a two-page memo sent to Capitol Hill Tuesday.
Community Pharmacy Contractual Framework negotiations have now begun for the 2024/25 and 2025/26 funding agreements, the government has announced. The government sent a letter to Community Pharmacy England (CPE) on Monday to signal the start of the negotiations, the Department of Health and Social Care (DHSC) said today. Minister of state for care Stephen Kinnock […] The post BREAKING: Pharmacy contract negotiations begin for 2024/25 and 2025/26 appeared first on The Pharmacist.
Earlier this month, a newer patient came in to see me for a check-up and discussion about her extremely high cholesterol level. In her late 50s with a family history of early-age heart attack, she was in a high-risk group for future stroke and coronary heart disease. When I suggested that a statin drug would help mitigate this risk, she replied with something I’m increasingly hearing from patients: “I’m really not a medicine person.
The National Pharmacy Association (NPA) would still recommend that pharmacies reduce their services if the upcoming pharmacy funding offer does not meet its requirements, it has suggested. Negotiations for the 2024/25 and 2025/26 Community Pharmacy Contractual Frameworks began this week, the government announced today. NPA chair Nick Kaye said he welcomed the start of discussions […] The post NPA doubles down on collective action threat as funding talks begin appeared first on The Pharmaci
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning, happy Tuesday. I was recently reading an interview with Lucy Dacus — one of my favorite musicians — and was surprised to see longevity science come up. Lucy’s take? “I think it’s silly that these people are trying to live forever, because they’re not going to do it.
Overview and rise of the emerging biotech startup space in India. Indias Biotechnology landscape is positioned for rapid growth, underpinned by robust R&D initiatives, a thriving culture of innovation, constant upskilling, and a strong commitment to sustainability. Both private biotech companies and the government have emerged as key enablers, propelling the sector towards achieving a transformative $300 billion bioeconomy milestone by 2030.
100
100
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Overview and rise of the emerging biotech startup space in India. Indias Biotechnology landscape is positioned for rapid growth, underpinned by robust R&D initiatives, a thriving culture of innovation, constant upskilling, and a strong commitment to sustainability. Both private biotech companies and the government have emerged as key enablers, propelling the sector towards achieving a transformative $300 billion bioeconomy milestone by 2030.
As changes to the U.S. regulatory foundation take hold, pharmas need to change their strategies to keep innovation — and the bottom line — above the surface.
Unlock the Secrets of Patent Term Extension: A Step-by-Step Guide As a pharmaceutical professional, you know how crucial it is to maximize the lifespan of your patented products. Patent term extension (PTE) can be a game-changer, but navigating the complex process can be daunting. That's why we've created a comprehensive guide to help you calculate PTE with confidence.
Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month post-surgical visit as part of phase 1b/2a of the NCT05693558 trial. The trial is to monitor the results of an investigational tissue regeneration product from Novadip, NVD003. The product is derived from adipose stem cells […] The post Results from Novadip phase 1b/2a trial reveal 88% efficacy appeared first on Pharmafile.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.
Get ready to climb a Crisco-covered light pole ! DCIs hometown Philadelphia Eagles are going to Super Bowl LIX! Go E-L-G-S-E-S! ( No, that's not a typo. ) Before you overturn any cars, please enjoy this months playbook of articles, intercepted for you from the Drug Channels gridiron: Touchdown! How Mark Cuban would quarterback the U.S. healthcare system Trick Play : Patients and plans get sacked by a gross spending-to-net bubble Defensive line : A comeback for pharmacy students Offensive lin
Vect-Horus, a private biotechnology company specialising in molecular development, has announced the appointment of Jrme Berger to its board of directors. Mr Berger bring experience from his previous role at Orange Group as president and managing partner. From this role, he garnered experience by overseeing investments in technology start-ups. As global head of financing and […] The post Jrme Berger announced as strategy and finance executive at Vect-Horus appeared first on Pharmafile.
Updated Phase III analysis show that Itovebi TM (inavolisib) in combination with palbociclib (Ibrance ) and fulvestrant provided a statistically significant and clinically meaningful overall survival benefit in a type of HR-positive advanced breast cancer. This was compared to palbociclib and fulvestrant only. The combination treatment more than doubled progression-free survival, according to Roches Phase III INAVO120 study results in PIK3CA-mutated, hormone receptor (HR)-positive, human epider
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ahead of chemotherapy in a variety of tumors.
Bring your waiting experience to life with Virtual Reality (VR)! Discover how VR technology is revolutionising the way we pass the time and enhancing customer satisfaction.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Antara Senior Care, part of the Max Group, has partnered with Wellbeing Nutrition. The collaboration aims to leverage Antaras understanding of senior health needs and Wellbeing Nutritions expertise in creating evidence-based nutraceuticals to co-create products designed specifically for older adults. These products aim to address identified nutritional gaps, offering seniors and their caregivers easy access to research-backed solutions through online and offline channels.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The new indication for semaglutide adds to the long list of conditions that the GLP-1 receptor agonist has been approved for, and provides a new option for high-risk patients with these chronic conditions.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
363 
Let's personalize your content